Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer.
Stockholm University.
Show others and affiliations
2003 (English)In: Int J Cancer, ISSN 0020-7136, Vol. 105, no 4, 472-9 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2003. Vol. 105, no 4, 472-9 p.
Keyword [en]
Carcinoma; Small Cell/*drug therapy, DNA Repair, DNA-Activated Protein Kinase, DNA-Binding Proteins/genetics/*physiology, Drug Resistance; Neoplasm, Etoposide/*pharmacology, Humans, Lung Neoplasms/*drug therapy, Nuclear Proteins, Protein-Serine-Threonine Kinases/pharmacology, Rad51 Recombinase, Tumor Cells; Cultured
Identifiers
URN: urn:nbn:se:su:diva-20292PubMedID: 12712436OAI: oai:DiVA.org:su-20292DiVA: diva2:186818
Available from: 2007-11-23 Created: 2007-11-23 Last updated: 2011-01-13Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12712436&dopt=Citation

Search in DiVA

By author/editor
Lundin, CeciliaHelleday, Thomas
By organisation
Stockholm University

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 39 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf